Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from…
Glenmark’s current portfolio consists of 175 products authorised for distribution in the US marketplace and 48 ANDAs pending…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Wockhardt
Wockhardt gets CDSCO approval to export upto 100 million doses of Sputnik vaccines
Wockhardt’s bulk vaccine and fill-finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly…
Wockhardt Q2 net profit zooms over 11-fold to Rs 37.17 crores
The company had posted a net profit of Rs 3.29 crores for the corresponding period of the previous fiscal, Wockhardt said in a…
Redefining job roles to build competitive compliance
Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
Wockhardt to receive upfront and milestone payments, in addition to royalties
RDIF and Wockhardt partner to produce Sputnik V and Sputnik Light vaccines
The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing…
High Commissioner of India visits Wockhardt UK
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK…
UK government extends contract with Wockhardt to fill-finish COVID-19 vaccines
This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be…
Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine
The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS,…